Ads
related to: hiv drug database- Patient Cost Support Info
Eligible Patients May Pay As Little
As $0 Co-Pay. Learn More Today.
- Resistance Data
Find Resistance Data Of
An HIV-1 Treatment Option.
- Prescribing Information
See Full Prescribing Information &
Boxed Warning For BIKTARVY®
- Register For Updates
Register To Receive Updates
About An HIV-1 Treatment.
- Dosing & Administration
Find Information About Dosing And
Administration At The HCP Site.
- Prescribing Info
See Full Prescribing Information
For An HIV-1 Treatment.
- Patient Cost Support Info
Search results
Results From The WOW.Com Content Network
HIV Drug Resistance Database, also known as Stanford HIV RT and Protease Sequence Database, is a database at Stanford University that tracks 93 common mutations of HIV.It has been recompiled in 2008 listing 93 common mutations, after its initial mutation compilation in 2007 of 80 mutations.
Resistance Database Initiative Logo. HIV Resistance Response Database Initiative (RDI) was formed in 2002 to use artificial intelligence (AI) to predict how patients will respond to HIV drugs using data from more 250,000 patients from around 50 countries around the world.
The ChemDB HIV, Opportunistic Infection and Tuberculosis Therapeutics Database is a publicly available tool developed by the National Institute of Allergy and Infectious Diseases to compile preclinical data on small molecules with potential therapeutic action against HIV/AIDS and related opportunistic infections.
HIV drug resistance poses an issue because it reduces the possible HIV medications a person can take due to cross resistance. In cross resistance, an entire class of medication is considered ineffective in lowering a patient's HIV viral load because all the drugs in a given class share the same mechanism of action. [7]
A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start ...
(Reuters) - Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell cheaper copycat versions of its HIV prevention medicine in 120 ...
Islatravir (MK-8591), Merck’s investigational drug, is being evaluated in multiple early and late-stage clinical trials in combination with other antiretroviral therapies for the treatment of HIV-1.
NAHDAP's staff consists of professional researchers, data archivists and technicians working together to obtain, process, distribute, and promote amongst social science researchers sharing of data relevant to drug addiction and HIV. NAHDAP is a project of the National Institute on Drug Abuse, part of the National Institutes of Health.
Ads
related to: hiv drug database